| IGFBP-4 and PAPP-A in normal physiology and disease R Hjortebjerg Growth Hormone & IGF Research 41, 7-22, 2018 | 70 | 2018 |
| The ZBED6–IGF2 axis has a major effect on growth of skeletal muscle and internal organs in placental mammals S Younis, M Schönke, J Massart, R Hjortebjerg, E Sundström, ... Proceedings of the National Academy of Sciences 115 (9), E2048-E2057, 2018 | 69 | 2018 |
| Current IGFBP-related biomarker research in cardiovascular disease—we need more structural and functional information in clinical studies A Hoeflich, R David, R Hjortebjerg Frontiers in endocrinology 9, 388, 2018 | 51 | 2018 |
| Determination of IGFs and their binding proteins R Hjortebjerg, J Frystyk Best Practice & Research Clinical Endocrinology & Metabolism 27 (6), 771-781, 2013 | 46 | 2013 |
| PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinoma J Thomsen, R Hjortebjerg, U Espelund, G Ørtoft, P Vestergaard, ... Oncotarget 6 (31), 32266, 2015 | 42 | 2015 |
| PAPP-A, IGFBP-4 and IGF-II are secreted by human adipose tissue cultures in a depot-specific manner MF Gude, R Hjortebjerg, C Oxvig, AA Thyø, NE Magnusson, M Bjerre, ... European journal of endocrinology 175 (6), 509-519, 2016 | 37 | 2016 |
| IGFBP-4 fragments as markers of cardiovascular mortality in type 1 diabetes patients with and without nephropathy R Hjortebjerg, L Tarnow, A Jorsal, HH Parving, P Rossing, M Bjerre, ... The Journal of Clinical Endocrinology & Metabolism 100 (8), 3032-3040, 2015 | 37 | 2015 |
| Insulin‐like growth factor binding protein 4 fragments provide incremental prognostic information on cardiovascular events in patients with ST‐segment elevation myocardial … R Hjortebjerg, S Lindberg, S Pedersen, R Mogelvang, JS Jensen, C Oxvig, ... Journal of the American Heart Association 6 (3), e005358, 2017 | 36 | 2017 |
| Insulin-like growth factor bioactivity, stanniocalcin-2, pregnancy-associated plasma protein-A, and IGF-binding protein-4 in pleural fluid and serum from patients with … US Espelund, M Bjerre, R Hjortebjerg, TR Rasmussen, A Lundby, ... The Journal of Clinical Endocrinology & Metabolism 102 (9), 3526-3534, 2017 | 33 | 2017 |
| The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage R Hjortebjerg, E Laugesen, P Høyem, C Oxvig, B Stausbøl-Grøn, ... European Journal of Endocrinology 176 (5), 521-531, 2017 | 33 | 2017 |
| PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCI R Hjortebjerg, S Lindberg, S Hoffmann, JS Jensen, C Oxvig, M Bjerre, ... Clinical Biochemistry 48 (4-5), 322-328, 2015 | 33 | 2015 |
| Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes R Hjortebjerg, A Flyvbjerg, J Frystyk Expert opinion on therapeutic targets 18 (2), 209-224, 2014 | 32 | 2014 |
| Depot-specific and GH-dependent regulation of IGF binding protein-4, pregnancy-associated plasma protein-A, and stanniocalcin-2 in murine adipose tissue R Hjortebjerg, DE Berryman, R Comisford, EO List, C Oxvig, M Bjerre, ... Growth Hormone & IGF Research 39, 54-61, 2018 | 25 | 2018 |
| Pregnancy-associated plasma proteins and Stanniocalcin-2–Novel players controlling IGF-I physiology J Frystyk, E Teran, MF Gude, M Bjerre, R Hjortebjerg Growth Hormone & IGF Research 53, 101330, 2020 | 23 | 2020 |
| Effects of prednisolone on serum and tissue fluid IGF-I receptor activation and post-receptor signaling in humans N Ramshanker, M Aagaard, R Hjortebjerg, TS Voss, N Møller, ... The Journal of Clinical Endocrinology & Metabolism 102 (11), 4031-4040, 2017 | 21 | 2017 |
| Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice NE Brooks, R Hjortebjerg, BE Henry, EO List, JJ Kopchick, DE Berryman Growth Hormone & IGF Research 30, 22-30, 2016 | 20 | 2016 |
| Serum galectin-1 in patients with multiple myeloma: Associations with survival, angiogenesis, and biomarkers of macrophage activation MN Andersen, M Ludvigsen, N Abildgaard, I Petruskevicius, R Hjortebjerg, ... OncoTargets and therapy, 1977-1982, 2017 | 19 | 2017 |
| The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2/PAPP-A/IGFBP-4 axis R Hjortebjerg, KL Thomsen, J Agnholt, J Frystyk BMC gastroenterology 19, 1-11, 2019 | 17 | 2019 |
| Insulin, IGF-1, and GH Receptors Are Altered in an Adipose Tissue Depot–Specific Manner in Male Mice With Modified GH Action R Hjortebjerg, DE Berryman, R Comisford, SJ Frank, EO List, M Bjerre, ... Endocrinology 158 (5), 1406-1418, 2017 | 16 | 2017 |
| Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4 R Hjortebjerg, KN Bojsen-Møller, M Søeby, C Oxvig, S Madsbad, J Frystyk Metabolism 124, 154886, 2021 | 12 | 2021 |
